NeuroPT - 22 - MS

5.0(1)
Studied by 10 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/46

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 8:24 PM on 4/18/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

47 Terms

1
New cards

females

MS is more common in (males/females)

2
New cards

20-40

MS has a typical onset between the age of _____-_____

3
New cards

farther

there is an increased prevalence of MS (closer/farther) the equator

4
New cards

epstein barr virus

the ____________ caused an increased risk of MS by 32x

5
New cards

autoimmune, selective demyelination

MS is an _________ process causing _____________ that affects the white matter of the CNS

6
New cards

TRUE

T/F: the disease course for MS is highly variable between individuals

7
New cards
  • CIS

  • RRMS

  • SPMS

  • PPMS

the 4 types of MS are:

8
New cards

optic nerve

the ________ is the only part of the peripheral nervous system affected by MS

9
New cards

CIS

______ MS is the first episode of symptoms

10
New cards

24 hours

CIS MS has to last at least _____

11
New cards

monofocal

(mono/multi)-focal CIS is a single system, like optic neuritis

12
New cards

multifocal

(mono/multi)-focal CIS is optic neuritis with numbness/tingling

13
New cards

MRI activity

CIS with __________ is much more likely to develop MS within several years

14
New cards

relapsing remitting RRMS

______ is the most common initial type of MS diagnoses

15
New cards

secondary progressive SPMS

_______ is the type of MS that most people with RRMS progress to

16
New cards

TRUE

T/F: there can be progression of the MS with SPMS without symptoms being present

17
New cards

MRIs

routine _____ are important for patients with MS

18
New cards

primary progressive PPMS

________ is the subtype of MS with accumulation of symptoms without early relapses or remissions

19
New cards

spinal cord

PPMS more commonly affects the (cortical area/spinal cord)

20
New cards
  • dissemination in space (2 different places in the brain)

  • dissemination in time (2 separate times of MRI activity)

the two main diagnostic criteria for a diagnosis of MS are:

  • ______________

  • ______________

21
New cards

symptoms

the locations of MRI lesions with MS correspond directly to __________

22
New cards

medial longitudinal fasciculus

the _______________ coordinates eye movements, and 40-75% of people with MS have difficulty with this causing double vision

23
New cards
  • optic nerves

  • posterior columns

  • corticospinal tracts

  • cerebellar peduncles

  • medial longitudinal fasciculus

common areas of impact for ME: (5)

24
New cards

FATIGUE

a very common symptom of MS that needs to be managed is ___________

25
New cards

HEAT

MS is fatigue and symptoms are exacerbated by _______

26
New cards

nearly all of them possible EXCEPT

  • hypokinesia

  • perceptual deficits

  • verticality deficits

which movement system diagnoses may be possible with MS:

27
New cards

disease modifying drugs

the treatment approach for MS long term is ____________

28
New cards

>24 hours

a relapse or acute exacerbation of MS is defined as new or increased symptoms lasting _______

29
New cards

pseudo relapse

a __________ of MS is symptoms lasting less than 24 hours and are usually caused by exercise, heat exposure, fatigue, or UTI

30
New cards

immunomodulators

pharmaceutical management for MS called ________________ can be used via injections, oral medications, or infusions

31
New cards

ocrevus

_______ is the only FDA approved med for PPMS

32
New cards

CNS getting infected

using pharmaceuticals and disease modifying medications like immunomodulators for MS causes an increased risk for ______________

33
New cards

effective

the big trade off with meds for MS is that safe meds aren’t very __________

34
New cards

diagnosis

for MS, it is recommended to start disease modifying drugs at ____________

35
New cards
  • failure to control disease

  • side effects are intolerable

  • adverse event

    • fatal brain infection by JC virus

  • inability to follow treatment regimen

  • more appropriate treatment becomes available

disease modifying drugs for MS should be continued indefinitely UNLESS: (read)

36
New cards

ampyra

_______ is a medication specifically FDA approved to improve gait speed and endurance for people with MS

37
New cards

NOT

a person living with MS (would/would not) have perceptual deficits

38
New cards
  • timed 25 ft walk

  • modified fatigue impact scale

  • 12 item MS walking scale

three MS specific outcome measures are:

39
New cards

research

the clinical disability EDSS for MS is most commonly used in the ________ setting

40
New cards

deposit, save, spend

fatigue MANAGEMENT (not conservation) can be thought of as a bank where there is ______ energy, ________ energy, and _________ energy that essentially goes by the week

41
New cards
  • sleep hygiene

  • REGULAR EXERCISE

people with MS can deposit energy into their bank through: (2)

42
New cards
  • compensatory strategies (bracing, AD, WC, DME)

  • manage heat/stress

people with MS can save energy in their bank through: (2)

43
New cards
  • delegate tasks to others as able

  • consider big events within the week

people with MS can spend energy strategically from their bank through: (2)

44
New cards

FAMILIAR

if someone is treating patients with MS, they need to be _________ with MS

45
New cards

autonomic dysfunction

people with MS can have blunted _______________ with exercise training, causing abnormal pressor response, blunted CV response to exercise, and syncope

46
New cards

RPE

you should always use _____ and monitor closely when doing exercising training for people with MS

47
New cards

good, bad

people with MS have _____ days and _____ days and may need different DME depending on the day